GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Net Current Asset Value

YSB (HKSE:09885) Net Current Asset Value : HK$2.68 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is YSB Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

YSB's net current asset value per share for the quarter that ended in Dec. 2023 was HK$2.68.

The historical rank and industry rank for YSB's Net Current Asset Value or its related term are showing as below:

HKSE:09885' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.04   Med: 3.07   Max: 3.07
Current: 3.04

During the past 4 years, the highest Price-to-Net-Current-Asset-Value Ratio of YSB was 3.07. The lowest was 3.04. And the median was 3.07.

HKSE:09885's Price-to-Net-Current-Asset-Value is ranked better than
70.8% of 250 companies
in the Healthcare Providers & Services industry
Industry Median: 6.23 vs HKSE:09885: 3.04

YSB Net Current Asset Value Historical Data

The historical data trend for YSB's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Net Current Asset Value Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Current Asset Value
-6.11 -7.29 -8.43 2.68

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Net Current Asset Value Get a 7-Day Free Trial -7.29 - -8.43 2.37 2.68

Competitive Comparison of YSB's Net Current Asset Value

For the Pharmaceutical Retailers subindustry, YSB's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YSB's Price-to-Net-Current-Asset-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where YSB's Price-to-Net-Current-Asset-Value falls into.



YSB Net Current Asset Value Calculation

YSB's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(5319.09-3640.43--39.621-0)/640.485
=2.68

YSB's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(5319.09-3640.43--39.621-0)/640.485
=2.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


YSB  (HKSE:09885) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


YSB Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of YSB's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


YSB (HKSE:09885) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
Executives
Chu Mang Yee 2201 Interest of corporation controlled by you
Meta Group Limited 2201 Interest of corporation controlled by you
Sounda Properties Limited 2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. 2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd. 2201 Interest of corporation controlled by you
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
Guo Guangchang 2201 Interest of corporation controlled by you
Fosun Holdings Limited 2201 Interest of corporation controlled by you
Fosun International Holdings Ltd. 2201 Interest of corporation controlled by you
Fosun International Limited 2201 Interest of corporation controlled by you
Miyt Holdings Limited 2101 Beneficial owner

YSB (HKSE:09885) Headlines

No Headlines